Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cangrelor Ticagrelor Transition Study
NCT01766466Phase 2Completed
- Sponsor
- The Medicines Company
- Start
- Jan 2013
- Primary completion
- Feb 2013
- Modality
- Nucleic Acid-Directed Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of cangrelor in coronary artery disease (CAD), sponsored by The Medicines Company. Started Jan 2013; status: completed.
02
Drugs
cangrelor
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT01766466.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01766466.